Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119103962 | 11910396 | 2 | F | 20160826 | 20160112 | 20160826 | EXP | GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2004-000014 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160826 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119103962 | 11910396 | 1 | PS | VIDEX | DIDANOSINE | 1 | Unknown | 250 MG, QD | U | 20156 | 250 | MG | QD | ||||||
| 119103962 | 11910396 | 2 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 500 MG, QD | U | 0 | 500 | MG | QD | ||||||
| 119103962 | 11910396 | 3 | SS | VIRAMUNE | NEVIRAPINE | 1 | Unknown | 400 MG, QD | U | 0 | 400 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119103962 | 11910396 | 1 | HIV infection |
| 119103962 | 11910396 | 2 | HIV infection |
| 119103962 | 11910396 | 3 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119103962 | 11910396 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119103962 | 11910396 | Pregnancy | |
| 119103962 | 11910396 | Stillbirth |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |